U.S. market Closed. Opens in 3 hours 53 minutes

PTPI | Petros Pharmaceuticals, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
Revenue5.82M5.99M7.81M9.56M15.58M
Cost of Revenue4.91M2.29M1.60M4.05M7.43M
Gross Profit908.20K3.70M6.21M5.51M8.15M
Operating Expenses11.67M19.55M24.26M22.80M25.02M
Selling, General & Admin9.26M12.21M15.59M15.67M19.73M
Research & Development2.41M1.74M1.79M459.64KN/A
Other Operating Expenses-11.09M5.60M6.88M6.66M5.29M
Operating Income-10.76M-15.85M-18.05M-17.28M-16.87M
Other Expenses / Income2.60M-4.19M9.06M-4.73M-16.29M
Before Tax Income-8.16M-20.04M-8.99M-22.01M-33.16M
Income Tax Expenses5.65B7.00M368.66K-1.43M-645.87K
Net Income-8.16M-27.04M-9.36M-20.59M-32.51M
Interest Expenses536.14K596.02K368.66K3.05M13.84M
Basic Shares Outstanding2.18M2.07M1.09M970.76K170.70K
Diluted Shares Outstanding2.18M2.07M1.09M970.76K170.70K
EBITDA-7.35M-6.84M-11.17M-10.62M-11.58M
EBITDA Margin-126.19%-114.20%-143.00%-111.11%-74.32%
EBIT5.64B-19.44M-8.62M-18.96M-19.31M
EBIT Margin96,929.03%-324.46%-110.33%-198.36%-123.98%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙